Adjunctive therapy in anaemia management

Nephrology Dialysis Transplantation

Volumn 17, Issue SUPPL. 5, 2002, Pages 56-59

  Hörl, Walter H ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anaemia; Carnitive; Chronic kidney disease; Erythropoietin; Iron; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CARNITINE; FERROUS GLUCONATE; FERROUS SULFATE; IRON DERIVATIVE; IRON DEXTRAN; MELATONIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; IRON;

ANAPHYLAXIS; ANEMIA; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE LIFESPAN; ERYTHROPOIESIS; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; IRON ABSORPTION; IRON INTAKE; IRON THERAPY; KIDNEY FAILURE; NAUSEA AND VOMITING; OXIDATIVE STRESS; PATIENT MONITORING; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION; CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANEMIA; CARNITINE; DIETARY SUPPLEMENTS; ERYTHROPOIETIN, RECOMBINANT; HUMANS; IRON; KIDNEY FAILURE, CHRONIC; OXIDATIVE STRESS;

EID: 0036319286     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.suppl_5.56     Document Type: Article

References (48)

1. Is there a role for adjuvant therapy in patients being treated with epoetin?
2. Erythropoietin and iron
3. A randomized trial of iron deficiency testing strategies in hemodialysis patients
4. Evaluating iron sufficiency: A clear view
5. Suspected iron dextran-related adverse drug events in hemodialysis patients
6. Intravenous administration of iron in epoetintreated haemodialysis patients-which drugs, which regimen?
7. Experience with a large dose (500 mg) of i.v. dextran and saccharate in peritoneal dialysis patients
8. Intravenous iron sucrose: Established a safe dose
9. Iron absorption in erythropoietin-treated haemodialysis patients: Effects of iron availability, inflammation and aluminium
10. The absorption of iron is disturbed in recombinant human erythropoietin-treated peritoneal dialysis patients
11. Is absorption of high-dose oral iron sufficient in peritoneal dialysis patients?
12. Intravenous infusion of total dose iron is superior to oral iron in treatment of anaemia in peritoreal dialysis study
13. Anemia and chronic renal failure. The possible role of the oxidative state of glutathione
14. Redox state, antioxidative activity and lipid peroxidation in erythrocytes and plasma of chronic ambulatory peritoneal dialysis patients
15. Does long-term treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialyzed patients?
16. Red blood cell lipid peroxidation in predialysis chronic renal failure
17. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients
18. Effects of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients
19. Oxidation parameters in complete correction of renal anemia
20. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients
21. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment
22. Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin
23. Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation
24. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure
25. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis
26. Erythropoietin and oxidative stress in haemodialysis: Beneficial effects of vitamin E supplementation
27. Oxidative stress in hemodialysis
28. Effects of iron on lipid peroxidation
29. Redox cycling of iron and lipid peroxidation
30. Iron-induced lipid peroxidation in whole blood in vitro as determined by malondialdehyde and luminol-enhanced chemiluminescence: Implications for iron supplementation to iron-depleted patients
31. Oxidized heme proteins in an animal model of hemochromatosis
32. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation
33. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: Improvement during vitamin E supplementation
34. Vitamin A attenuates oxidative stress induced by intravenous iron in patients on hemodialysis
35. Melatonin prevents oxidative stress resulting from iron and erythropoietin administration
36. Long-term L-carnitine treatment of chronic anaemia of patients with end-stage renal failure
37. Endocrine metabolic effects of L-carnifine in patients on regular dialysis treatment
38. Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: Decisive role of low levels of high-density lipoprotein-cholesterol
39. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients
40. Effect of low dose of L-carnitine on the response to recombinant human erythropoietin in hemodialyzed children: About two cases
41. L-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin
42. Response to recombinant human erythropoietin (r-HuEPO) and L-carnitine combination in patients with anemia of end-stage renal disease
43. L-Carnitine and erythropoietin requirements in hemodialysis patients
44. Entry of acetyl-L-carnitine into biosynthetic pathways
45. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients
46. Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients
47. The required dose of erythropoietin during renal anemia treatment is related to the degree of impairment in erythrocyte deformability
48. Anemia and carnitine supplementation in hemodialyzed patients